NLRP3 and colitis: In a DSS-induced colitis model, NLRP3 (−/−) mice were shown to release less IL-1β, a central factor in the pathogenesis of IBD, and NLRP3 (−/−) mice were less likely to exhibit colitis than wild-type controls (Bauer et al., 2010).